B

Braster SA
WSE:BRA

Watchlist Manager
Braster SA
WSE:BRA
Watchlist
Price: 0.58 PLN Market Closed
Market Cap: 17m PLN

Net Margin
Braster SA

-1 513.4%
Current
-1 154%
Average
1.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 513.4%
=
Net Income
-4.3m
/
Revenue
284k

Net Margin Across Competitors

No Stocks Found

Braster SA
Glance View

Market Cap
17m PLN
Industry
Health Care

Braster SA engages in the development and manufacturing of medical devices for self-examination. The firm provides research and development on breast cancer. The company applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The firm cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

BRA Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 513.4%
=
Net Income
-4.3m
/
Revenue
284k
What is the Net Margin of Braster SA?

Based on Braster SA's most recent financial statements, the company has Net Margin of -1 513.4%.

Back to Top